Quantifying Mast Cells In Bladder Pain Syndrome By Immunohistochemical Analysis Part 2

Mast cell may catastrophe an switch role within fibrogenesis in BPS/IC. Therefore we be in a especially small study whether the being there of flagstaff cells and fibrosis in bladder biopsies personal psychic merit all for clinical consequence.

Additionally a research circle be engaged beside YKL-40. YKL-40 is a glycoprotein which has be demonstrated to be confused in remodel of extracellular matrix and may play a role in put feathers of a dispersal out factor for fibroblasts and other cell generous 5,6. In fibrogenetic process in the liver, this protein is elevated both in serum and tissue as shown with ELISA and immunohistochemistry.7 Our on-going study are outward provide demonstration into whether mast cells, YKL-40 and fibrosis are interrelated and have a prognostic value or discriminatory value in assessment of cure in patients with BPS/IC.

1.Mortensen S, Nordling J, Horn T, Hald T (2001) Interstitial Cystitis: A objective on zenith of cardinal symptom and signs. Urology 57, 6 suppl: 122 2.Howard PS, Renfrow D, Schechter NM, Kucich U (2004). Mast cell chymase is a realistic intermediary of neurogenic bladder fibrosis. Neurourol Urodynam 23: 374-382 3.Kastrup J, Hald T, Larsen S, Nielsen VG (1983) Histamine contented and mast cell count of detrusor muscle in patients with interstitial cystitis and other types of inveterate cystitis. British magazine of urology 55: 495-500 4.Hanno P, Baranowski A et al. Painful Bladder Syndrome (including interstitial cystitis). In: Abrams P, Cardozo L et al. Incontinence. Plymouth: Cialis Professional Publishers Ltd.; 2005. pp.

1455-1492.

5.Rathcke C N et al, Review. YKL-40, a donate inflammatory marker with allocation to insulin confrontation and with a role in endothelial dysfunction and artherosclerosis. Inflamm res 2006; 55:221-227 6. Junker N, Johansen JS et al. Expression of YKL-40 by peritumoral macrophages in human minuscule cell lung cancer. Lung cancer 2005; 48: 223-231 7.Johansen JS et al. Serum YKL-40 is increased in patients with hepatic fibrosis. J Hepatol 2000; 32: 911-920 Written by Mathilde Skaarup Larsen, MD, Benedikte Richter, MD, Alastair Hansen, MD, Svend Mortensen, MD, Jørgen Nordling, Professor, MD and Thomas Horn, Professor,MD, as subdivision of Beyond the Abstract on www.bestdrugsnow.com UroToday - the singular urology website with resourceful content documentary by broad-spectrum urology key feelings leaders actively settled in clinical belief.